Table 2.
E′ | E/E′ | E/A | LA volume index | LV mass index | ||||||
---|---|---|---|---|---|---|---|---|---|---|
β | P | β | P | β | P | β | P | β | P | |
Age, year | −0.435 | <0.001 | 0.462 | <0.001 | −0.421 | <0.001 | 0.184 | 0.007 | −0.063 | 0.355 |
WC, cm | −0.341 | <0.001 | 0.270 | 0.001 | −0.259 | <0.001 | 0.030 | 0.658 | 0.152 | 0.026 |
SBP, mmHg | −0.344 | <0.001 | 0.285 | <0.001 | −0.347 | <0.001 | 0.117 | 0.086 | 0.300 | <0.001 |
BMI, kg/m2 | −0.305 | <0.001 | 0.280 | <0.001 | −0.229 | <0.001 | 0.050 | 0.461 | 0.204 | 0.003 |
VFA, cm2 | −0.389 | <0.001 | 0.293 | <0.001 | −0.379 | <0.001 | −0.027 | 0.686 | 0.026 | 0.696 |
HbA1c | −0.331 | <0.001 | 0.271 | <0.001 | −0.289 | <0.001 | −0.004 | 0.944 | −0.065 | 0.343 |
HOMA-IR | −0.153 | 0.025 | 0.112 | 0.103 | −0.163 | 0.017 | −0.044 | 0.515 | 0.001 | 0.991 |
Adiponectin, μg/ml | 0.139 | 0.041 | −0.017 | 0.796 | 0.049 | 0.473 | 0.062 | 0.367 | −0.174 | 0.011 |
Creatinine, mg/dl | −0.128 | 0.060 | −0.025 | 0.712 | −0.029 | 0.664 | −0.071 | 0.297 | 0.051 | 0.457 |
HDL-C, mg/dl | 0.160 | 0.019 | −0.075 | 0.272 | 0.085 | 0.216 | −0.007 | 0.918 | −0.050 | 0.465 |
Triglyceride, mg/dl | −0.139 | 0.043 | 0.061 | 0.373 | −0.148 | 0.030 | −0.095 | 0.164 | 0.046 | 0.498 |
Hemoglobin, mg/dl | −0.150 | 0.029 | −0.050 | 0.466 | −0.136 | 0.047 | −0.232 | 0.001 | 0.034 | 0.618 |
WC, waist circumference; SBP. Systolic blood pressure; BMI, body mass index; VFA, visceral fat area; HbA1c, glycosylated hemoglobin; HOMA-IR, homeostasis model assessment of insulin resistance; HDL-C, high-density lipoprotein cholesterol.